Figure 3.

Immunolocalization of the SZP in the rat muscle-derived mesenchymal stem/progenitor cells (MDMSCs). Control (A), 3 ng/ml of TGF-β1 (B), and 300 ng/ml BMP-7 (C), treated for three days.

Andrades et al. Arthritis Research & Therapy 2012 14:R72   doi:10.1186/ar3793
Download authors' original image